By InvitationNot Applicable

US and MRI of the Forefoot: Intermetatarsal Bursitis or Morton's Neuroma

Denmark75 participantsStarted 2021-06-14

Plain-language summary

The aim of this study is to investigate the incidence of intermetatarsal bursitis and Morton's neuroma in patients with metatarsalgia (i.e. pain in the forefoot) and control subjects by diagnostic imaging with ultrasound and MRI.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 years * Pain in an intermetatarsal space (patient group) Exclusion Criteria: * Age \<18 years * Open wounds or ongoing infection in the forefoot at the time of examination * Persons with contraindications to participate in MRI scan * Persons with a history of significant trauma in the forefoot, e.g. any fracture or previous surgeries in the forefoot * Persons who have previously received treatment for Morton's neuroma in the same foot, e.g. injection (within 6 months) or operation (anytime) * Persons with severely impaired renal function (GFR \<30 ml/min) * Persons with a systemic inflammatory condition like rheumatoid arthritis, due to clinically silent intermetatarsal bursitis in this group (control group)

What they're measuring

Incidence of intermetatarsal bursitis on MRI

Timeframe: 8 weeks

Incidence of intermetatarsal bursitis on US

Timeframe: 8 weeks

Incidence of Morton's neuroma on MRI

Timeframe: 8 weeks

Incidence of Morton's neuroma on US

Timeframe: 8 weeks

Incidence of other pathology on MRI

Timeframe: 8 weeks

Incidence of other pathology on US

Timeframe: 8 weeks

Incidence of normal findings on MRI

Timeframe: 8 weeks

Incidence of normal findings on US

Timeframe: 8 weeks

Trial details

NCT IDNCT05685160

SponsorRigshospitalet, Denmark

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01

View on ClinicalTrials.gov More Intermetatarsal Bursitis trials